1-(2,3-环氧基丙基)-4-叔丁氧基羰基哌嗪 | 159873-06-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 中文名称: 1-(2,3-环氧基丙基)-4-叔丁氧基羰基哌嗪
• 英文名称: tert-butyl 4-(oxiran-2-ylmethyl)piperazine-1-carboxylate
• 英文别名: (S)-4-Oxiranylmethyl-piperazine-1-carboxylic acidtert-butyl ester
• CAS: 159873-06-0
• 化学式: C₁₂H₂₂N₂O₃
• 分子量: 242.318
• InChiKey: XDRGUPXMFDJOFK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.92
• 拓扑面积：
  45.3
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT

反应信息

• 作为反应物：
  描述：

  1-(2,3-环氧基丙基)-4-叔丁氧基羰基哌嗪 在 草酰氯 、 二乙胺基三氟化硫 、 sodium hydride 、 二甲基亚砜 、 三乙胺 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 38.5h， 生成 3,6-Dibromo-9-(2,2-difluoro-3-piperazin-1-yl-propyl)-9H-carbazole
  参考文献：
  名称：

  3,6-Dibromocarbazole Piperazine Derivatives of 2-Propanol as First Inhibitors of Cytochrome c Release via Bax Channel Modulation

  摘要：

  There is compelling evidence that Bax channel activity stimulates cytochrome c release leading ultimately to cell death, which is a key event in ischemic injuries and neurodegenerative diseases. Here 3,6-dibromocarbazole piperazine derivatives of 2-propanol are described as the first small and potent modulators of the cytochrome c release triggered by Bid-induced Bax activation in a mitochondrial assay. Furthermore, a mechanism of action is proposed, and fluorescent derivatives allowing the localization of such inhibitors are reported.

  DOI：

  10.1021/jm034107j
• 作为产物：
  描述：

  环氧溴丙烷 、 N-Boc-哌嗪 在 potassium carbonate 作用下， 以 乙腈 为溶剂， 生成 1-(2,3-环氧基丙基)-4-叔丁氧基羰基哌嗪
  参考文献：
  名称：

  [EN] SMALL MOLECULE BAX INHIBITORS AND USES THEREOF
  [FR] INHIBITEURS BAX À PETITES MOLÉCULES ET UTILISATIONS ASSOCIÉES

  摘要：

  本文揭示了用于治疗需要抑制BAX的疾病或疾病的化合物、组合物及使用这些化合物的方法，例如心血管疾病或疾病。

  公开号：

  WO2018165494A1

文献信息

• Piperazine and homopiperazine derivatives, pharmaceutical compositions
  申请人：Gyogyszerkutato Intezet KFT

  公开号：US05380724A1

  公开（公告）日：1995-01-10

  This invention relates to novel compounds of the general formula (I) and the pharmaceutically acceptable acid addition salts thereof. In the general formula (I) ##STR1## wherein Lip, A.sup.1, A.sup.2, Het and n are defined as in the specification. The compounds of the general formula (I) inhibit the lipid peroxidation and therefore, they are useful for the treatment or prevention of diseases and conditions wherein the inhibition of lipid peroxidation is desirable.

  本发明涉及具有通式(I)的新颖化合物及其药学上可接受的酸加成盐。在通式(I)中，其中Lip、A1、A2、Het和n如说明书中所定义。通式(I)的化合物抑制脂质过氧化，因此，它们可用于治疗或预防需要抑制脂质过氧化的疾病和状况。
• 9-(Piperazinylalkyl)carbazoles as Bax-modulators
  申请人：Applied Research Systems ARS Holding N.V.

  公开号：EP1094063A1

  公开（公告）日：2001-04-25

  The present invention is related to piperazine derivatives of carbazole notably for use as pharmaceutically active compounds, as well as to pharmaceutical formulations containing such piperazine derivatives of carbazole. Said piperazine derivatives of carbazole are efficient modulators, in particular inhibitors, of the Bax function and/or activation. The present invention is furthermore related to novel piperazine derivatives of carbazole as well as methods of their preparation.

  本发明涉及哌嗪衍生物的咔唑，特别用作药用活性化合物，以及含有这种哌嗪衍生物的咔唑的药物配方。所述的哌嗪衍生物的咔唑是有效的调节剂，特别是Bax功能和/或激活的抑制剂。本发明还涉及新型哌嗪衍生物的咔唑以及其制备方法。
• 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles
  申请人：Tsubouchi Hidetsugu

  公开号：US20060094767A1

  公开（公告）日：2006-05-04

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R 1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R 2 represents a group —OR 3 or the like, and R 3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R 1 and —(CH 2 ) n R 2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R 41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis , multi-drug-resistant Mycobacterium tuberculosis , and atypical acid-fast bacteria.

  本发明提供了一种2,3-二氢-6-硝基咪唑并[2,1-b]噁唑化合物，其通式如下：其中，R1代表氢原子或C1-C6烷基，n代表0到6的整数，R2代表—OR3或类似的基团，R3代表氢原子、C1-C6烷基或类似的基团，或者R1和—(CH2)nR2可以通过相邻的碳原子通过氮原子结合在一起形成一个螺环，其通式为（H）：其中，R41为氢、C1-C6烷基或类似的基团。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型酸性快速细菌具有优异的杀菌作用。
• [EN] 9- (PIPERAZINYLALKYL) CARBAZOLES AS BAX-MODULATORS<br/>[FR] 9- (PIPERAZINYLALKYL) CARBAZOLES UTILES EN TANT QUE MODULATEURS DE BAX
  申请人：APPLIED RESEARCH SYSTEMS

  公开号：WO2001029028A1

  公开（公告）日：2001-04-26

  The present invention is related to piperazine derivatives of carbazole of formula (I) notably for use as pharmaceutically active compounds, as well as to pharmaceutical formulations containing such piperazine derivatives of carbazole. Said piperazine derivatives of carbazole are efficient modulators, in particular efficient inhibitors, of the Bax function and/or activation. The present invention is furthermore related to novel piperazine derivatives of carbazole as well as methods of their preparation.

  本发明涉及式(I)的嘧啶二酰胺衍生物，特别是作为药物活性化合物的使用，以及含有这种嘧啶二酰胺衍生物的制药配方。所述嘧啶二酰胺衍生物是高效的调节剂，特别是高效的抑制剂，对Bax功能和/或激活具有作用。本发明还涉及新的嘧啶二酰胺衍生物以及其制备方法。
• 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles
  申请人：Otsuka Pharmaceutical Co., Ltd.

  公开号：US07262212B2

  公开（公告）日：2007-08-28

  The present invention provides a 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound represented by the following general formula: wherein R1 represents a hydrogen atom or C1-C6 alkyl group, n represents an integer of 0 to 6, R2 represents a group —OR3 or the like, and R3 represents a hydrogen atom, C1-C6 alkyl group or the like, or R1 and —(CH2)nR2 may bind to each other together with carbon atoms adjacent thereto through nitrogen atoms so as to form a spiro ring represented by the general formula (H): wherein R41 is hydrogen, C1-C6 alkyl group or the like. The present compound has an excellent bactericidal action against Mycobacterium tuberculosis, multi-drug-resistant Mycobacterium tuberculosis, and atypical acid-fast bacteria.

  本发明提供一种由以下通式表示的2,3-二氢-6-硝基咪唑并[2,1-b]噁唑化合物：其中R1代表氢原子或C1-C6烷基，n代表0到6的整数，R2代表-OR3基团或类似基团，R3代表氢原子、C1-C6烷基或类似基团，或R1和-(CH2)nR2可以与相邻的碳原子通过氮原子结合在一起，形成由通式（H）表示的螺环：其中R41是氢、C1-C6烷基或类似基团。该化合物对结核分枝杆菌、多药耐药结核分枝杆菌和非典型酸性快速菌具有优异的杀菌作用。